

Need a doctor who can prescribe Striverdi Respimat for COPD? Learn which specialists prescribe it, how to find one near you, and what to expect at your visit.
If you've been reading about Striverdi Respimat (Olodaterol) and think it might help your COPD symptoms, the first step is finding a doctor who can prescribe it. That sounds simple enough — but depending on where you live and what kind of insurance you have, it can take a little planning.
Striverdi Respimat is a once-daily maintenance inhaler for chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It's not a rescue inhaler, and it's not available over the counter. You'll need a prescription from a licensed healthcare provider. For more details about this medication, check out our guide on what Striverdi is, its uses, and dosage.
Here's how to find the right provider, what to expect at your appointment, and how to move forward once you have your prescription.
Several types of healthcare providers can prescribe Striverdi Respimat:
A pulmonologist is a lung specialist and the most common type of doctor to prescribe Striverdi. If you have moderate to severe COPD, your primary care doctor may refer you to a pulmonologist for more specialized treatment. Pulmonologists are especially helpful if you've tried other COPD medications without enough relief or if your symptoms are getting worse.
Many internal medicine and family medicine physicians manage COPD and can prescribe Striverdi. If your COPD is mild to moderate and well-controlled, your primary care doctor may be able to handle your treatment without a specialist referral. This is often the fastest route to a prescription.
For older adults, a geriatrician — a doctor who specializes in care for seniors — may manage your COPD along with other age-related conditions. Geriatricians understand how COPD medications interact with other treatments common in older patients.
Yes, you can get a Striverdi prescription through telehealth. Many virtual care platforms now offer visits with doctors who specialize in respiratory conditions. This can be a great option if you live in a rural area, have mobility issues, or just want a faster appointment. Just make sure the telehealth provider is licensed in your state.
Once you know what type of doctor to look for, here's how to actually find one:
Start with your insurance company's online provider directory. Search for pulmonologists or internal medicine doctors in your area who are in-network. This ensures you'll pay the lowest possible copay or coinsurance for your visit.
If you already have a primary care doctor, ask them for a referral to a pulmonologist. They can often recommend someone they trust and send over your medical records, which saves time at your first appointment.
Websites like Zocdoc, Healthgrades, and the American Lung Association's provider search tool can help you find lung specialists near you. You can filter by insurance accepted, patient reviews, and appointment availability.
If in-person options are limited, telehealth platforms like Teladoc, Amwell, and MDLive connect you with doctors who can prescribe COPD medications, including Striverdi. Appointments are often available within days — sometimes the same day.
Large hospital systems and academic medical centers usually have pulmonology departments. Their websites often let you search for doctors by specialty and schedule appointments online.
Here's what a typical visit looks like when you're seeking a Striverdi prescription:
Your doctor will likely:
If your doctor determines that Striverdi is appropriate, they'll write a prescription. They should also show you how to use the Respimat inhaler or direct you to a resource that can help.
Be sure to tell your doctor if you:
For more on drug interactions to be aware of, see our guide on Striverdi drug interactions.
Once your doctor prescribes Striverdi, there are a few things to keep in mind:
Not every pharmacy keeps Striverdi in stock. Before you drive across town, use a tool like Medfinder to check which pharmacies near you have it available. You can also read our guide on how to check if a pharmacy has Striverdi in stock without calling.
The cash price for Striverdi Respimat ranges from $275 to $400 per inhaler (a one-month supply). If that's more than you expected, there are ways to bring the price down:
For the full breakdown, see our article on how to save money on Striverdi.
The Respimat device is different from a standard metered-dose inhaler. You'll need to insert the cartridge, prime the device before first use, and take two slow, steady inhalations once a day. Your pharmacist can walk you through the process, or you can watch instructional videos on the Boehringer Ingelheim website.
Your doctor will want to see you for follow-up visits to check how Striverdi is working for you. These visits are a chance to report any side effects, adjust your treatment plan, and make sure your COPD is being managed as well as possible. For a look at potential side effects, see our article on Striverdi side effects and when to call your doctor.
Finding a doctor who can prescribe Striverdi Respimat doesn't have to be complicated. Whether you start with your primary care doctor, get a referral to a pulmonologist, or try a telehealth visit, the important thing is to take that first step. COPD is a progressive condition, and getting on the right treatment early can make a real difference in your daily life.
Once you have your prescription, Medfinder can help you find a pharmacy with Striverdi in stock near you — so you can spend less time searching and more time breathing easier.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.